IBDEI0TX ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13765,2)
 ;;=^106083
 ;;^UTILITY(U,$J,358.3,13766,0)
 ;;=S05.31XA^^80^765^13
 ;;^UTILITY(U,$J,358.3,13766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13766,1,3,0)
 ;;=3^Ocular Laceration Right Eye w/o Prolapse/Loss of Intraoc Tissue,Init Encntr
 ;;^UTILITY(U,$J,358.3,13766,1,4,0)
 ;;=4^S05.31XA
 ;;^UTILITY(U,$J,358.3,13766,2)
 ;;=^5020606
 ;;^UTILITY(U,$J,358.3,13767,0)
 ;;=S05.32XA^^80^765^12
 ;;^UTILITY(U,$J,358.3,13767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13767,1,3,0)
 ;;=3^Ocular Laceration Left Eye w/o Prolapse/Loss of Intraoc Tissue,Init Encntr
 ;;^UTILITY(U,$J,358.3,13767,1,4,0)
 ;;=4^S05.32XA
 ;;^UTILITY(U,$J,358.3,13767,2)
 ;;=^5020609
 ;;^UTILITY(U,$J,358.3,13768,0)
 ;;=Z21.^^80^765^2
 ;;^UTILITY(U,$J,358.3,13768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13768,1,3,0)
 ;;=3^Asymptomatic HIV Infection Status
 ;;^UTILITY(U,$J,358.3,13768,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,13768,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,13769,0)
 ;;=Z83.511^^80^765^6
 ;;^UTILITY(U,$J,358.3,13769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13769,1,3,0)
 ;;=3^Family Hx of Glaucoma
 ;;^UTILITY(U,$J,358.3,13769,1,4,0)
 ;;=4^Z83.511
 ;;^UTILITY(U,$J,358.3,13769,2)
 ;;=^5063382
 ;;^UTILITY(U,$J,358.3,13770,0)
 ;;=Z83.518^^80^765^5
 ;;^UTILITY(U,$J,358.3,13770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13770,1,3,0)
 ;;=3^Family Hx of Eye Disorder NEC
 ;;^UTILITY(U,$J,358.3,13770,1,4,0)
 ;;=4^Z83.518
 ;;^UTILITY(U,$J,358.3,13770,2)
 ;;=^5063383
 ;;^UTILITY(U,$J,358.3,13771,0)
 ;;=Z79.899^^80^765^10
 ;;^UTILITY(U,$J,358.3,13771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13771,1,3,0)
 ;;=3^Long Term Current Drug Therapy NEC
 ;;^UTILITY(U,$J,358.3,13771,1,4,0)
 ;;=4^Z79.899
 ;;^UTILITY(U,$J,358.3,13771,2)
 ;;=^5063343
 ;;^UTILITY(U,$J,358.3,13772,0)
 ;;=Z01.00^^80^765^4
 ;;^UTILITY(U,$J,358.3,13772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13772,1,3,0)
 ;;=3^Eye/Vision Exam w/o Abnormal Findings
 ;;^UTILITY(U,$J,358.3,13772,1,4,0)
 ;;=4^Z01.00
 ;;^UTILITY(U,$J,358.3,13772,2)
 ;;=^5062612
 ;;^UTILITY(U,$J,358.3,13773,0)
 ;;=Z01.01^^80^765^3
 ;;^UTILITY(U,$J,358.3,13773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13773,1,3,0)
 ;;=3^Eye/Vision Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,13773,1,4,0)
 ;;=4^Z01.01
 ;;^UTILITY(U,$J,358.3,13773,2)
 ;;=^5062613
 ;;^UTILITY(U,$J,358.3,13774,0)
 ;;=E05.90^^80^765^21
 ;;^UTILITY(U,$J,358.3,13774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13774,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec
 ;;^UTILITY(U,$J,358.3,13774,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,13774,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,13775,0)
 ;;=92015^^81^766^1^^^^1
 ;;^UTILITY(U,$J,358.3,13775,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13775,1,2,0)
 ;;=2^Refraction
 ;;^UTILITY(U,$J,358.3,13775,1,3,0)
 ;;=3^92015
 ;;^UTILITY(U,$J,358.3,13776,0)
 ;;=92311^^81^767^3^^^^1
 ;;^UTILITY(U,$J,358.3,13776,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13776,1,2,0)
 ;;=2^Contact Lens-Aphakia OD/OS
 ;;^UTILITY(U,$J,358.3,13776,1,3,0)
 ;;=3^92311
 ;;^UTILITY(U,$J,358.3,13777,0)
 ;;=92312^^81^767^4^^^^1
 ;;^UTILITY(U,$J,358.3,13777,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13777,1,2,0)
 ;;=2^Contact Lens-Aphakia OU
 ;;^UTILITY(U,$J,358.3,13777,1,3,0)
 ;;=3^92312
 ;;^UTILITY(U,$J,358.3,13778,0)
 ;;=92340^^81^767^6^^^^1
 ;;^UTILITY(U,$J,358.3,13778,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13778,1,2,0)
 ;;=2^Glasses Fitting, Monofocal
 ;;^UTILITY(U,$J,358.3,13778,1,3,0)
 ;;=3^92340
 ;;^UTILITY(U,$J,358.3,13779,0)
 ;;=92341^^81^767^5^^^^1
 ;;^UTILITY(U,$J,358.3,13779,1,0)
 ;;=^358.31IA^3^2
